Gather with other pharmacy professionals and visit the exhibit hall at the ASHP Summer Meetings & Exhibition, and learn how these companies and their products
DENVER, Jan. 24, 2023 — Leiters, a trusted FDA-registered 503B outsourcing provider of compounded sterile preparations and pharmacy services, announced today that it has appointed
Leiters Elevating the Standards in 503B Pharmaceutical Outsourcing. With increasing regulatory pressure and the need to reduce costs while improving the patient experience, access to
Leiters Elevating the Standards in 503B Pharmaceutical Outsourcing. With increasing regulatory pressure and the need to reduce costs while improving the patient experience, access to
Peruse the groundbreaking Exhibit Hall, and learn for yourself how these innovative companies and their products are helping to define what is important to your
Product & Service Providers in: ADMIXTURE COMPOUNDING SERVICES (503B OUTSOURCING FACILITIES) 340B IV/INFUSION ADHERENCE As Seen In: View Leiters’ Ad:
Leiters Elevating the Standards in 503B Pharmaceutical Outsourcing. With increasing regulatory pressure and the need to reduce costs while improving the patient experience, access to
Continuing drug shortages and escalating drug costs. Increasing medication waste due to shortened in-house shelf life. And evolving regulations causing costly investments in equipment and
Leiters is a trusted FDA-registered 503B outsourcing provider of compounded sterile preparations committed to providing healthcare professionals and their patients with the highest-quality medications. Company
DENVER, June 29, 2022 /PRNewswire/ — Leiters, a trusted FDA-registered 503B outsourcing provider of compounded sterile preparations and pharmacy services, announced today it has joined
